Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the Light Study, a long-term research study of Contrave® (naltrexone SR/bupropion SR), a new, investigational drug being evaluated for weight loss, has begun enrolling patients at clinical sites throughout the United States. The Light Study is designed to assess the cardiovascular health outcomes of Contrave.
Nearly 93 million Americans are affected by obesity, and that number is predicted to increase to 120 million Americans within the next five years. More than one-third of adults in the United States are affected by obesity. Obesity increases the risk of heart disease, type 2 diabetes, some types of cancer, sleep apnea, and a variety of other conditions. Medical research suggests that losing just five percent of your body weight can significantly improve your health and reduce the risk of complications from type 2 diabetes and heart disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56480-lightstudy
As a new survey conducted online by Harris Interactive on behalf of Nutrisystem among over 3,000 U.S adults in December, indicates more than half of Americans (54 percent) are planning to make New Year’s resolutions to lose weight. Nutrisystem (NASDAQ: NTRI), the leading provider of home-delivered weight loss meal plans, is gearing up to help them succeed in keeping those resolutions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59643-nutrisystem-survey-weight-loss-new-year-s-resolutions
Witness to Fitness: Pumped Up! Powered Up! All Things Are Possible!
In Witness to Fitness, Donna Richardson Joyner, brings together faith, food, and fitness for 28 day program that will help you lose weight while you nourish both your body and your soul. Find out more at http://www.DonnaRichardson.com/book or http://bit.ly/WitnessToFitness Christian/Fitness/Motivational/Wellness
Amway North America today launched BODYKEY by NUTRILITE™, a weight management program rooted in genetics that reveals exactly how a person should eat to most effectively manage their weight.
BODYKEY by NUTRILITE weight loss plans are based on an individual’s unique genetic makeup. The new program combines eating well, fitness, nutrition and a take-at-home genetic test to determine if a person’s body responds better to cutting carbs, reducing fat or a balanced diet.
To view Multimedia News Release, go to http://www.multivu.com/players/English/60257-amway-bodykey/
Eisai Inc. announced today that BELVIQ (pronounced BEL-VEEK) will be available to eligible patients by prescription in the United States beginning June 11.
BELVIQ was approved by the U.S. Food and Drug Administration on June 27, 2012 to be used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults who have a body mass index (BMI) of 30 kg/m² or greater (obese), or BMI of 27 kg/m² or greater (overweight) with at least one weight-related medical condition such as high blood pressure, high cholesterol, or type 2 diabetes. It is not known if BELVIQ is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products, nor is it known if BELVIQ changes your risk of heart problems or stroke, or of death due to heart problems or stroke.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/60316-eisai-belviq-civ-chronic-weight-management-tablets-for-overweight-adults
There is a growing body of evidence linking yogurt consumption to improved health, and additional research to identify the scientific link between yogurt and potential health benefits, is underway scientists say. International nutrition experts gathered at the First Global Summit on the Health Effects of Yogurt in Boston on April 24, 2013 to present the current state of the science on the health effects of yogurt and identify research gaps that need to be addressed within the scientific community.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61206-american-society-nutrition-health-effects-yogurt-weight-chronic-disease
Weight loss topped the list of New Year’s resolutions in 2014 for nearly 50% of Americans who participate in this annual tradition. To help those seeking healthier lifestyles, Amway North America recently launched three new products as part of its BODYKEY by NUTRILITE™ personalized weight management program: BODYKEY™ Slim Soup™ Mix, BODYKEY™ Slim Popcorn, and BODYKEY™ Meal Replacement Shake in Rich Creamy Strawberry.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61027-amway-bodykey-by-nutrilit-products-to-jump-start-weight-loss-for-life
Whether looking to get slimmer and leaner or healthier and stronger, it is now more rewarding than ever with ViSalus’ PROJECT 10 Challenge. Developed to recognize and motivate people to achieve their health goals, PROJECT 10™ will award $10,000 every week in 2014 to 10 people ($1,000 each) who lose 10 lbs. or add 10 lbs. of lean muscle during their Body by Vi Challenge™.
Beginning today, people can visit challenge.com to start their PROJECT 10 Challenge by choosing a category and uploading a video. Every Monday, ViSalus will reveal the 10 weekly winners, and for each 10 lbs. lost, the company will donate 30 Vi-Shape® Nutritional Shake meals to a child in need through their PROJECT 10™ Kids program. Representing an entire month of nutritious breakfast, lunch or snack options, the donation puts an at-risk or overweight child on the path to a healthier life.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/63082-visalus-fitness-weight-loss-resolution-reward-win-1k-lose-10-lb
Eisai Inc. today announced the launch of a new national television advertising campaign for BELVIQ® (lorcaserin HCl) CIV, an FDA-approved prescription therapy for chronic weight management. The advertisement will air on numerous channels including Lifetime, Oxygen and AMC.
The spot illustrates the struggles many people face when they are trying to lose or control their weight. BELVIQ is presented as a targeted approach to weight loss, that, when combined with diet and increased activity, may help some patients lose weight and keep it off.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7161051-eisai-launches-national-television-campaign-belviq-lorcaserin-hcl-civ
Eisai Inc. today announced the launch of My Healthy™, an interactive and motivational campaign that shifts the focus of the obesity conversation away from just pounds lost to health gained. Almost 70 percent of Americans are affected by obesity or overweight. This movement emphasizes that those affected by obesity or overweight with a related health condition can benefit from small positive changes, including modest weight loss.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7131331-eisai-inc-my-healthy-promise-liberate-your-closet/
EnteroMedics Inc. (NASDAQ: ETRM) today announced that the U.S. Food and Drug Administration (FDA) has approved VBLOC® vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients with obesity who have a Body Mass Index (BMI) of at least 40 to 45 kg/m2, or a BMI of at least 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight management program within the past five years. The Maestro System is the first new medical device to be approved by the FDA for obesity in over ten years. EnteroMedics anticipates that the device will be available, on a limited basis, at select Bariatric Centers of Excellence in the U.S. this year. The Maestro System has received CE Mark and is listed on the Australian Register of Therapeutic Goods.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7269351-enteromedics-fda-approval-vbloc-maestro-system-weight-loss-device/
Weight is a heavy topic for millions of Americans – an estimated 69 percent are overweight. Eating right and staying active are cornerstones of health and wellness – and top-of-mind for those who know that weight management is a lifestyle not a fad. Yet hectic schedules, limited convenient options and diet fatigue often make it difficult to make consistently good choices.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7239459-amway-bodykey-by-nutrilite/
